Erlotinib and Temsirolimus for Solid Tumors

NCT00770263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Erlotinib
DRUG: Temsirolimus

Sponsor

Washington University School of Medicine

Collaborators

[object Object]